ABBVIE INC. vs. MacroGenics, Inc.
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABBV | MGNX | |
|---|---|---|
| Market Cap | $467.12 billion | $238.24 million |
| Revenue (TTM) | $64.39 billion | $153.62 million |
| Net Income (TTM) | $6.32 billion | $-14,592,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | MGNX | |
|---|---|---|
| P/E Ratio | 74.67 | — |
| Price / Book | -79.33 | 5.56 |
| Price / Sales | 7.25 | 1.55 |
ABBV and MGNX split the valuation factors evenly.
Profitability
| ABBV | MGNX | |
|---|---|---|
| Net Margin | 9.81% | -9.50% |
| Return on Equity | -107.29% | -34.04% |
ABBV and MGNX split the profitability factors evenly.
Dividend
| ABBV | MGNX | |
|---|---|---|
| Dividend Yield | 2.62% | — |
| Payout Ratio | 195.48 | — |
ABBV and MGNX split the dividend factors evenly.
Risk & Sentiment
| ABBV | MGNX | |
|---|---|---|
| Short Interest | 0.85% | 7.54% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, MGNX overview, MGNX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.